341 results on '"Bunnik, Eline M"'
Search Results
2. Should Patients Be Allowed to Pay Out of Pocket? The Ethical Dilemma of Access to Expensive Anti-cancer Treatments in Universal Healthcare Systems: A Dutch Case Study
3. Awe and anxiety for cancer cells: connecting scientists and patients in a holistic approach of metastasis research
4. An Ethical Perspective on the Social Value of Cell-Based Technologies in Type 1 Diabetes
5. Expanded access to investigational drugs in psychiatry: A systematic review
6. The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessment
7. No need for options for choice for unsolicited findings in informed consent for clinical genetic testing
8. Beyond severity: utility as a criterion for setting the scope of RGCS
9. Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer’s Dementia?: Applying the Method of Reflective Equilibrium for a Clinical Dilemma
10. Impact of incidental findings on young adult participants in brain imaging research: an interview study
11. Ethics of allocation of donor organs
12. Organoids: a systematic review of ethical issues
13. Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
14. The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians’ Views and Experiences in The Netherlands
15. The End of Personification:The Mereological Fallacy in Science Communication on Brain Organoids
16. Ethics of access to newly approved expensive medical treatments:multi-stakeholder dialogues in a publicly funded healthcare system
17. 233.10: Inequitable Access to Transplants: Adults With Impaired Decision-Making Capacity
18. Secondary research use of personal medical data: attitudes from patient and population surveys in The Netherlands and Germany
19. Access to Non‐reimbursed Expensive Cancer Treatments: A Justice Perspective.
20. The End of Personification : The Mereological Fallacy in Science Communication on Brain Organoids
21. Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens’ attitudes
22. Public Engagement with Human Germline Editing Requires Specification
23. Access to Non‐reimbursed Expensive Cancer Treatments: A Justice Perspective
24. On the personal utility of Alzheimer's disease-related biomarker testing in the research context
25. Correction: Secondary research use of personal medical data: attitudes from patient and population surveys in The Netherlands and Germany
26. Correction to: Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer’s Dementia?
27. Ethics of access to newly approved expensive medical treatments: multi-stakeholder dialogues in a publicly funded healthcare system.
28. Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and Psychosocial Interdisciplinary Considerations and Key Recommendations
29. Ethics of routine : a critical analysis of the concept of 'routinisation' in prenatal screening
30. Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs
31. Can Voluntary Health Insurance for Non-reimbursed Expensive New Treatments Be Just?
32. An assessment of the moral value of neuronal cell models and brain organoids
33. What do patients with unmet medical needs want? A qualitative study of patients’ views and experiences with expanded access to unapproved, investigational treatments in the Netherlands
34. Vulnerable person investigation plan (VIP) to optimise inclusion in clinical trials
35. Symbolic Value of Brain Organoids: Shifting the Focus from Consciousness to Sociocultural Perspectives on Resemblance
36. Expanded access to investigational drugs in psychiatry:A systematic review
37. Access to Non-reimbursed Expensive Cancer Treatments:A Justice Perspective
38. Clinical Translation of Bio-Artificial Pancreas Therapies:Ethical, Legal and Psychosocial Interdisciplinary Considerations and Key Recommendations
39. Awe and anxiety for cancer cells:connecting scientists and patients in a holistic approach of metastasis research
40. Can Voluntary Health Insurance for Non-reimbursed Expensive New Treatments Be Just?
41. Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis
42. Access to effective but expensive treatments:An analysis of the solidarity argument in discussions on funding of medical treatments
43. Incidental findings in population imaging revisited
44. Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis
45. Access to effective but expensive treatments: An analysis of the solidarity argument in discussions on funding of medical treatments
46. Personal utility in genomic testing: is there such a thing?
47. Do genomic tests enhance autonomy?
48. Early-Phase Clinical Trials of Bio-Artificial Organ Technology
49. Ethical Frameworks for Disclosure of Alzheimer Disease Biomarkers to Research Participants: Conflicting Norms and a Nuanced Policy
50. Physicians’ Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.